Skip to main content
Log in

Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells

  • Original Papers
  • Clinical Oncology or Epidemiology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

The proliferation of three mammary carcinoma cell lines was explored for the effectiveness of dihydrotestosterone (DHT) and the antiandrogenic substances cyproterone acetate (CPA) or hydroxyflutamide. The cell growth, determined in multiple experimental cultures of the estrogen-sensitive lines MCF-7 and EFM-19, was stimulated by 10-9 M to 10-6 M DHT, whereas estrogen-resistant MFM-21 cells were unresponsive to the hormonal factors applied. Growth-promoting effects of 10-8 M to 10-6 M CPA were detected in cultures of those cell lines which were sensitive to estrogen and androgen. Competition experiments with DHT and the antiandrogens suggested involvement of the androgen receptor in the stimulation of cell growth by CPA. Participation of the estrogen receptor was excluded by lack of competition between CPA and the enhancement of proliferation by estradiol-17β. At the receptor level the anti-androgens were able to compete with androgen binding. The results of the study demonstrate androgenic properties of CPA in regard to the growth of human mammary carcinoma cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Allegra JC, Lippman ME, Thompson EG, Simon R, Green L, Barlock A, Huff KK, Aitkin S, Do HMT, Warren R (1979) Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen and glucocorticoid receptors in human breast cancer. Cancer Res 39:1447–1454

    PubMed  Google Scholar 

  • Blossey HC, Bartsch HH, Köbberling J (1982) Die mögliche klinische Bedeutung des Androgenrezeptors in Mammakarzinomen. In: Jonat W, Maass H (Hrsg) Steroidhormonrezeptoren im Karzinomgewebe Enke, Stuttgart, S. 164–170

    Google Scholar 

  • Bryan RM, Mercer RJ, Benett RC, Rennie GC, Lie TH, Morgan FJ (1984) Androgen receptors in breast cancer. cancer 54:2436–2440

    PubMed  Google Scholar 

  • Butler WB, Berlinski PJ, Hillman RM, Kelsey WH, Toenniges MM (1986) Relation of in vitro properties to tumorgenicity for a series of sublines of the human breast cancer cell line MCF-7. Cancer Res 46:6339–6348

    PubMed  Google Scholar 

  • CCNSC Breast Cancer Group (1964) Testosterone propionate therapy in breast cancer. J Am Med Assoc 188:1069–1070

    Google Scholar 

  • Cole MP, Jones CTA, Todd IDH (1971) A new antiestrogenic agent in late breast cancer. Br J Cancer 25:270–275

    PubMed  Google Scholar 

  • Darbre P, Yates J, Curtis S, King RJB (1983) Effect of estradiol on human breast cancer cells in vitro. Cancer Res 43:349–354

    PubMed  Google Scholar 

  • Dawood MY, Saxena BB (1976) Plasma testosterone and dihydrotestosterone in ovulatory and anovulatory cycles. Am J Obstet Gynecol 126:430–435

    PubMed  Google Scholar 

  • Dixon M, Webb C (1971) Enzymes, 2nd edn. Longman, London

    Google Scholar 

  • Hackenberg R, Schulz K-D, Schmidt-Rhode P, Hölzel F, Sturm G, Würz H, Reusch K (1986) Antiandrogens in breast cancer. Rev Endocrine Rel Cancer, suppl 18(63):57–60

    Google Scholar 

  • Hofmann J, Sernetz M (1983) A kinetic study on the enzymatic hydrolysis of fluoresceindiacetate and fluorescein-di-β-D-galactopyranoside. Anal Biochem 131:180–185

    PubMed  Google Scholar 

  • Hölzel F, Albrecht M, Simon WE, Hänsel M, Metz R, Schweizer J, Dietel M (1985) Effectiveness of antineoplastic drugs on the proliferation of human mammary and ovarian carcinoma cells in monolayer culture. J Cancer Res Clin Oncol 109:217–226

    PubMed  Google Scholar 

  • Hölzel F, Simon WE, Albrecht M (1986) Untersuchungen an Zellkulturen von Mammakarzinomen. Einfluß von Proteo- und Steroidnormonen auf DNA-Synthese und Zellwachstum. In: Bellmann O, Krebs D, Totović V (Hrsg) Hormonabhängigkeit des mammakarzinoms. Aktuelle diagnostische Möglichkeiten. Zuckschwerdt, München, S. 122–135 (Aktuelle Onkologie, vol 31)

    Google Scholar 

  • Horwitz KB, Costlow ME, McGuire WL (1975) MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone and glucocorticoid receptors. Steroids 26:785–795

    PubMed  Google Scholar 

  • Horwitz KB, McGuire WL (1978) Estrogen control of progesterone receptor in human breast cancer. J Biol Chem 253:2223–2228

    PubMed  Google Scholar 

  • Kunzmann R, Hölzel F (1987) Karyotype alterations in human ovarian carcinoma cells during long-term cultivation and nude mouse passage. Cancer Genet Cytogenet 28:201–212

    PubMed  Google Scholar 

  • Liao S, Howell DK, Chang T-M (1974) Action of a nonsteroidal antiandrogen, flutamide, on the receptor binding and nuclear retention of 5α-dihydrotestosterone in rat ventral prostate. Endocirnology 94:1205–1209

    Google Scholar 

  • Lippman ME, Bolan G, Huff K (1975) Human breast cancer responsive to androgens in long-term tissue culture. Nature 258:339–341

    PubMed  Google Scholar 

  • Lippman ME, Bolan G, Huff K (1976a) The effect of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36:4599–4601

    Google Scholar 

  • Lippman ME, Bolan G, Huff K (1976b) The effect of androgens and antiandrogens on hormone-responsive breast cancer in long-term tissue culture. Cancer Res 36:4610–4618

    PubMed  Google Scholar 

  • Longcope C, Pratt JH, Schneider SH, Fineberg SE (1978) Aromatization of androgens by muscle and adipose tissue in vivo. J Clin Endocrinol Metab 46:146–152

    PubMed  Google Scholar 

  • MacDonald PC, Rombaut RP, Siiteri PK (1967) Plasma precursors of estrogen. I. Extent of conversion of plasma α-androstenedione to estrone in normal males and nonpregnant normal, castrate and adrenalectomized females. J Clin Endocrinol 27:1103–1111

    Google Scholar 

  • McIndoe JH, Etre LA (1981) An antiestrogenic action of androgens in human breast cancer cells. J Clin Endocrinol Metab 53:836–842

    PubMed  Google Scholar 

  • Miller MA, Lippman WE, Katzenellenbogen BS (1984) Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Cancer Res 44:5038–5045

    PubMed  Google Scholar 

  • Miller WR, Scott WN, Morris R, Fraser HM, Sharpe RM (1985a) Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 313:231–233

    PubMed  Google Scholar 

  • Miller WR, Telford J, Dixon JM, Hawkins RA (1985b) Androgen receptor activity in human breast cancer and its relationship with oestrogen and progesterone receptor activity. Br J Cancer Clin Oncol 21:539–542

    Google Scholar 

  • Mowszowicz I, Bieber DE, Chung KW, Bullock LP, Bardin CW (1974) Synandrogenic and antiandrogenic effect of progestins: Comparison with nonprogestational antiandrogens. Endocrinology 95:1589–1599

    PubMed  Google Scholar 

  • Nawata H, Bronzert D, Lippman ME (1981a) Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells. J Biol Chem 256:5016–5021

    PubMed  Google Scholar 

  • Nawata H, Chong MJ, Bronzert D, Lippman ME (1981b) Estradiol-independent growth of a subline of MCF-7 human breast cancer cells in culture. J Biol Chem 256:6895–6902

    PubMed  Google Scholar 

  • Neri R, Kassem N (1984) Biological and clinical properties of anti-androgens. Prog Cancer Res Ther 31:507–518

    Google Scholar 

  • Neumann F, Steinbeck H (1974) Antiandrogens. In: Eichler O, Herken M, Faruh H, Welch AD (Hrsg) Handbuch der experimentellen Pharmakologie, vol XXXV/2. Springer, Berlin Heidelberg New York, S. 235–484

    Google Scholar 

  • Osborne CK, Hobbs K, Clark GM (1985) Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45:584–590

    PubMed  Google Scholar 

  • Peets EA, Henson MF, Neri R (1974) On the mechanism of the anti-androgenic actionof flutamide (a-a-a-trifluoro-2-methyl-4′-nitro-m-propionotoluidide) in the rat. Endocrinology 94:532–540

    PubMed  Google Scholar 

  • Reddel RR, Murphy LC, Hall RE, Sutherland RL (1985) Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Cancer Res 45:1525–1531

    PubMed  Google Scholar 

  • Santen RJ (1986) Aromatase inhibitors for treatment of breast cancer: Current concepts and new perspectives. Breast Cancer Res Treat 7 [Suppl]:23–36

    PubMed  Google Scholar 

  • Schulz K-D, Kremer S, Würz H, Reusch K (1982) Cyproterone acetate in metastasizing breast cancer. Preliminary results. Verh Dtsch Krebsges 3:187

    Google Scholar 

  • Seibert K, Shafie SM, Triche TJ, Whang-Peng JJ, O'Brien SJ, Toney JH, Huff KK, Lippman WE (1983) Cronal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice. Cancer Res 43:2223–2239

    PubMed  Google Scholar 

  • Shafie SM, Grantham FH (1981) Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst 67:51–56

    PubMed  Google Scholar 

  • Shapiro E, Lippman M (1985) Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletion. J Steroid Biochem 22:15–20

    PubMed  Google Scholar 

  • Siiteri PK, MacDonald PC (1973) Role of extraglandular estrogen in human endocrinology. In: Geiger SR (ed) Handbook of Physiology, sect 7, vol II,1. Williams and Wilkins, Baltimore, pp 615–629

    Google Scholar 

  • Simon WE, Albrecht M, Trams G, Dietel M, Hölzel F (1984a) In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen and prolactin. J Natl Cancer Inst 73:313–321

    PubMed  Google Scholar 

  • Simon WE, Hänsel M, Dietel M, Matthiesen L, Albrecht M, Hölzel F (1984b) Alteration of steroid hormone sensitivity during the cultivation of human mammary carcinoma cells. In Vitro 20:157–166

    PubMed  Google Scholar 

  • Soule HD, Vasquez J, Long A, Albert S, Brennan MJ (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409–1413

    PubMed  Google Scholar 

  • Soule HD, McGrath CM (1980) Estrogen-responsive proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Lett 10:177–189

    PubMed  Google Scholar 

  • Stover EP, Krishnan AV, Feldman D (1987) Estrogen down-regulation of androgen receptors in cultured human mammary cancer cells (MCF-7). Endocrinology 120:2597–2603

    PubMed  Google Scholar 

  • Thomas DB (1986) Hormones and hormone receptors in the etiology of breast cancer. Breast Cancer Res Treat 7 [Suppl]:11–22

    Google Scholar 

  • Trams G, Maass H (1977) Specific binding of estradiol and dihydrotestosterone in human mammary cancers. Cancer Res 37:258–261

    PubMed  Google Scholar 

  • Vignon F, Lippman ME, Nawata H, Derocq D, Rochefort H (1984) Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF-7 cells. Cancer Res 44:2084–2088

    PubMed  Google Scholar 

  • Vorherr H, Messer RH (1978) Breast cancer: potentially predisposing and protecting factors. Role of pregnancy, lactation and endocrine status. Am J Obstet Gynecol 130:335–358

    PubMed  Google Scholar 

  • Wagner RK, Jungblut PW (1976) Oestradiol and dihydrotestosterone receptors in normal and neoplastic human mammary tissue. Acta Endocrinol 82:105–120

    PubMed  Google Scholar 

  • Whang-Peng J, Lee EC, Kao-Shan CS, Seibert K, Lippman M (1983) Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines. J Natl Cancer Inst 71:687–695

    PubMed  Google Scholar 

  • Wilding G, Chen M, Gelman EP (1987) LHRH agonists and human breast cancer cells. Nature 329:770

    PubMed  Google Scholar 

  • Würz H, Schulz K-D, Citoler P, Kaiser R (1982) Verteilung von Östrogen-, Gestagen-, Androgen- und Kortikosteroidrezeptoren in Mammakarzinomen. In: Jonat W, Maass H (Hrsg) Steroidhormonrezeptoren im Karzinomgewebe. Enke, Stuttgart, pp 23–30

    Google Scholar 

  • Zava DT, McGuire WL (1978) Androgen action through estrogen receptor in a human breast cancer cell line. Endocrinology 103:624–631

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

On the occasion of the 60th anniversary of Prof. Dr. H. Maass, Universitäts-Frauenklinik Hamburg

Supported by the Deutsche Forschungsgemeinschaft, SFB 215 (Tumor und Endokrinium) and Kempkes-Stiftung, Marburg

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hackenberg, R., Hofmann, J., Hölzel, F. et al. Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells. J Cancer Res Clin Oncol 114, 593–601 (1988). https://doi.org/10.1007/BF00398183

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00398183

Key words

Navigation